Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 211

1.

BAP1 (BRCA1-associated protein 1) is a highly specific marker for differentiating mesothelioma from reactive mesothelial proliferations.

Cigognetti M, Lonardi S, Fisogni S, Balzarini P, Pellegrini V, Tironi A, Bercich L, Bugatti M, Rossi G, Murer B, Barbareschi M, Giuliani S, Cavazza A, Marchetti G, Vermi W, Facchetti F.

Mod Pathol. 2015 Aug;28(8):1043-57. doi: 10.1038/modpathol.2015.65. Epub 2015 May 29.

2.

Loss of BAP1 Expression in Atypical Mesothelial Proliferations Helps to Predict Malignant Mesothelioma.

Pillappa R, Maleszewski JJ, Sukov WR, Bedroske PP, Greipp PT, Boland JM, Yi ES, Peikert T, Aubry MC, Roden AC.

Am J Surg Pathol. 2018 Feb;42(2):256-263. doi: 10.1097/PAS.0000000000000976.

PMID:
29076876
3.

Utility of BAP1 Immunohistochemistry and p16 (CDKN2A) FISH in the Diagnosis of Malignant Mesothelioma in Effusion Cytology Specimens.

Hwang HC, Sheffield BS, Rodriguez S, Thompson K, Tse CH, Gown AM, Churg A.

Am J Surg Pathol. 2016 Jan;40(1):120-6. doi: 10.1097/PAS.0000000000000529.

PMID:
26448191
4.

BAP1 Immunohistochemistry and p16 FISH in the Diagnosis of Sarcomatous and Desmoplastic Mesotheliomas.

Hwang HC, Pyott S, Rodriguez S, Cindric A, Carr A, Michelsen C, Thompson K, Tse CH, Gown AM, Churg A.

Am J Surg Pathol. 2016 May;40(5):714-8. doi: 10.1097/PAS.0000000000000616.

PMID:
26900815
5.

New Markers for Separating Benign From Malignant Mesothelial Proliferations: Are We There Yet?

Churg A, Sheffield BS, Galateau-Salle F.

Arch Pathol Lab Med. 2016 Apr;140(4):318-21. doi: 10.5858/arpa.2015-0240-SA. Epub 2015 Aug 19.

PMID:
26288396
6.

BAP1 immunohistochemistry and p16 FISH to separate benign from malignant mesothelial proliferations.

Sheffield BS, Hwang HC, Lee AF, Thompson K, Rodriguez S, Tse CH, Gown AM, Churg A.

Am J Surg Pathol. 2015 Jul;39(7):977-82. doi: 10.1097/PAS.0000000000000394.

PMID:
25634745
7.

Usefulness of p16/CDKN2A fluorescence in situ hybridization and BAP1 immunohistochemistry for the diagnosis of biphasic mesothelioma.

Wu D, Hiroshima K, Yusa T, Ozaki D, Koh E, Sekine Y, Matsumoto S, Nabeshima K, Sato A, Tsujimura T, Yamakawa H, Tada Y, Shimada H, Tagawa M.

Ann Diagn Pathol. 2017 Feb;26:31-37. doi: 10.1016/j.anndiagpath.2016.10.010. Epub 2016 Oct 22.

PMID:
28038708
8.

Diagnostic utility of BAP1 and EZH2 expression in malignant mesothelioma.

Shinozaki-Ushiku A, Ushiku T, Morita S, Anraku M, Nakajima J, Fukayama M.

Histopathology. 2017 Apr;70(5):722-733. doi: 10.1111/his.13123. Epub 2017 Jan 5.

PMID:
27859460
9.

PAX8 Expression in a Subset of Malignant Peritoneal Mesotheliomas and Benign Mesothelium has Diagnostic Implications in the Differential Diagnosis of Ovarian Serous Carcinoma.

Chapel DB, Husain AN, Krausz T, McGregor SM.

Am J Surg Pathol. 2017 Dec;41(12):1675-1682. doi: 10.1097/PAS.0000000000000935.

PMID:
28877056
10.

Loss of BRCA1-associated protein 1 (BAP1) expression is useful in diagnostic cytopathology of malignant mesothelioma in effusions.

Cozzi I, Oprescu FA, Rullo E, Ascoli V.

Diagn Cytopathol. 2018 Jan;46(1):9-14. doi: 10.1002/dc.23837. Epub 2017 Oct 10.

PMID:
28994508
11.

Loss of expression of BAP1 is a useful adjunct, which strongly supports the diagnosis of mesothelioma in effusion cytology.

Andrici J, Sheen A, Sioson L, Wardell K, Clarkson A, Watson N, Ahadi MS, Farzin M, Toon CW, Gill AJ.

Mod Pathol. 2015 Oct;28(10):1360-8. doi: 10.1038/modpathol.2015.87. Epub 2015 Jul 31.

12.

BAP1 loss is unusual in well-differentiated papillary mesothelioma and may predict development of malignant mesothelioma.

Lee HE, Molina JR, Sukov WR, Roden AC, Yi ES.

Hum Pathol. 2018 Sep;79:168-176. doi: 10.1016/j.humpath.2018.05.001. Epub 2018 May 12.

PMID:
29763720
13.

BAP1 immunohistochemistry and p16 FISH results in combination provide higher confidence in malignant pleural mesothelioma diagnosis: ROC analysis of the two tests.

Hida T, Hamasaki M, Matsumoto S, Sato A, Tsujimura T, Kawahara K, Iwasaki A, Okamoto T, Oda Y, Honda H, Nabeshima K.

Pathol Int. 2016 Oct;66(10):563-570. doi: 10.1111/pin.12453. Epub 2016 Sep 11.

PMID:
27614970
14.

The role of BRCA1-associated protein 1 in the diagnosis of malignant mesothelioma in effusion and fine-needle aspiration cytology.

Hatem L, McIntire PJ, He B, Gogineni S, Ho M, Mathew S, Margolskee EM, Siddiqui MT, Rao RA.

Diagn Cytopathol. 2019 Mar;47(3):160-165. doi: 10.1002/dc.24061. Epub 2018 Dec 6.

PMID:
30520251
15.

BAP1 facilitates diagnostic objectivity, classification, and prognostication in malignant pleural mesothelioma.

McGregor SM, Dunning R, Hyjek E, Vigneswaran W, Husain AN, Krausz T.

Hum Pathol. 2015 Nov;46(11):1670-8. doi: 10.1016/j.humpath.2015.06.024. Epub 2015 Jul 21.

PMID:
26376834
16.

A combination of MTAP and BAP1 immunohistochemistry in pleural effusion cytology for the diagnosis of mesothelioma.

Kinoshita Y, Hida T, Hamasaki M, Matsumoto S, Sato A, Tsujimura T, Kawahara K, Hiroshima K, Oda Y, Nabeshima K.

Cancer Cytopathol. 2018 Jan;126(1):54-63. doi: 10.1002/cncy.21928. Epub 2017 Oct 20.

17.

BAP1 immunohistochemistry has limited prognostic utility as a complement of CDKN2A (p16) fluorescence in situ hybridization in malignant pleural mesothelioma.

McGregor SM, McElherne J, Minor A, Keller-Ramey J, Dunning R, Husain AN, Vigneswaran W, Fitzpatrick C, Krausz T.

Hum Pathol. 2017 Feb;60:86-94. doi: 10.1016/j.humpath.2016.09.026. Epub 2016 Oct 19.

PMID:
27771374
18.

Loss of BRCA1-associated protein 1 (BAP1) expression is rare in non-small cell lung cancer.

Owen D, Sheffield BS, Ionescu D, Churg A.

Hum Pathol. 2017 Feb;60:82-85. doi: 10.1016/j.humpath.2016.10.005. Epub 2016 Oct 28.

PMID:
27984124
19.

[BRCA1 associated protein 1 (BAP1) expression in pleural diffuse malignant mesothelioma: A comparative cytological and histological analyses on 50 patients].

Jaouen A, Thivolet-Bejui F, Chalabreysse L, Piaton E, Traverse-Glehen A, Isaac S, Decaussin-Petrucci M, Depaepe L, Fontaine J, Remy I, Maury JM, Brevet M.

Ann Pathol. 2016 Apr;36(2):111-9. doi: 10.1016/j.annpat.2016.01.005. Epub 2016 Mar 16. French.

PMID:
26995100
20.

BAP1 Is Altered by Copy Number Loss, Mutation, and/or Loss of Protein Expression in More Than 70% of Malignant Peritoneal Mesotheliomas.

Leblay N, Leprêtre F, Le Stang N, Gautier-Stein A, Villeneuve L, Isaac S, Maillet D, Galateau-Sallé F, Villenet C, Sebda S, Goracci A, Byrnes G, McKay JD, Figeac M, Glehen O, Gilly FN, Foll M, Fernandez-Cuesta L, Brevet M.

J Thorac Oncol. 2017 Apr;12(4):724-733. doi: 10.1016/j.jtho.2016.12.019. Epub 2016 Dec 27.

Supplemental Content

Support Center